Clinical Trials Browser

Phase 2 × Neoplasms, Unknown Primary × pembrolizumab × Clear all

NCT03752333 2026-01-22

CUPem

Phase 2 Completed

Neoplasms, Unknown Primary

NCT03391973 2025-04-25

CUP

Phase 2 Active not recruiting

Neoplasms, Unknown Primary